Tagrisso 80mg Generic (Osimertinib)

Osimertinib 80mg

Third-generation EGFR-TKI indicated for metastatic non-small cell lung cancer with T790M mutation.

Brand
AstraZeneca / India Sourced
Active ingredient
Osimertinib Mesylate
Prescription
Required and pharmacist-reviewed

Final availability, price and import eligibility are confirmed for the destination before fulfilment.